Kymera Therapeutics, Inc. (KYMR)

Kymera Therapeutics Stock Forecast

Stock Price Forecast

The 25 analysts that cover Kymera Therapeutics stock have a consensus rating of "Strong Buy" and an average price target of $108.04, which forecasts a 29.40% increase in the stock price over the next year. The lowest target is $52 and the highest is $140.

Price Target: $108.04 (+29.40%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$52	$108.04	$118	$140
Change	-37.72%	+29.40%	+41.33%	+67.68%

Analyst Ratings

The average analyst rating for Kymera Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Oct '25	Nov '25	Dec '25	Jan '26	Feb '26	Mar '26
Strong Buy	9	10	12	12	12	13
Buy	9	9	11	11	12	12
Hold	0	0	0	1	1	1
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	18	19	23	24	25	26

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
David Dai UBS	UBS	Strong Buy Maintains $90 → $128	Strong Buy	Maintains	$90 → $128	+53.31%	Mar 3, 2026
Geoff Meacham Citigroup	Citigroup	Strong Buy Maintains $110 → $120	Strong Buy	Maintains	$110 → $120	+43.73%	Mar 2, 2026
Sudan Loganathan Stephens & Co.	Stephens & Co.	Buy Maintains $95 → $100	Buy	Maintains	$95 → $100	+19.77%	Mar 2, 2026
Jeet Mukherjee BTIG	BTIG	Strong Buy Maintains $138 → $134	Strong Buy	Maintains	$138 → $134	+60.50%	Feb 26, 2026
Biren Amin Piper Sandler	Piper Sandler	Buy Maintains $125 → $140	Buy	Maintains	$125 → $140	+67.68%	Feb 26, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

45.50M

Increased by 16.05%

from 39.21M

Revenue Next Year

47.69M

Increased by 4.79%

from 45.50M

EPS This Year

-3.78

from -3.69

EPS Next Year

-4.25

from -3.78

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	72.83M	46.83M	78.59M	47.07M	39.21M	45.50M	47.69M
Revenue Growth	114.00%	-35.71%	67.84%	-40.11%	-16.70%	16.05%	4.79%
EPS	-2.09	-2.87	-2.52	-2.98	-3.69	-3.78	-4.25
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	24	22

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2026	2027	2028	2029	2030
High	102.9M	102.9M
Avg	45.5M	47.7M
Low	9.8M	-12.7M

Revenue Growth

Revenue Growth	2026	2027	2028	2029	2030
High	162.5%	126.2%
Avg	16.0%	4.8%
Low	-75.0%	-

EPS Forecast

EPS	2026	2027	2028	2029	2030
High	-3.20	-3.08
Avg	-3.78	-4.25
Low	-4.13	-6.03

EPS Growth

EPS Growth	2026	2027	2028	2029	2030
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.